[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Maier et al., 2004 - Google Patents

Modulation of mammalian life span by the short isoform of p53

Maier et al., 2004

View PDF @Free from Publisher
Document ID
10715768010166663801
Author
Maier B
Gluba W
Bernier B
Turner T
Mohammad K
Guise T
Sutherland A
Thorner M
Scrable H
Publication year
Publication venue
Genes & development

External Links

Snippet

Overexpression of the short isoform of p53 (p44) has unexpectedly uncovered a role for p53 in the regulation of size and life span in the mouse. Hyperactivation of the insulin-like growth factor (IGF) signaling axis by p44 sets in motion a kinase cascade that clamps potentially …
Continue reading at genesdev.cshlp.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Similar Documents

Publication Publication Date Title
Maier et al. Modulation of mammalian life span by the short isoform of p53
Kong et al. IRF4 is a key thermogenic transcriptional partner of PGC-1α
Bagchi et al. HDAC11 suppresses the thermogenic program of adipose tissue via BRD2
Vieira et al. BRG1-SWI/SNF-dependent regulation of the Wt1 transcriptional landscape mediates epicardial activity during heart development and disease
Yan et al. Gonadal soma controls ovarian follicle proliferation through Gsdf in zebrafish
Akiyama et al. Interactions between Sox9 and β-catenin control chondrocyte differentiation
Ding et al. Targeting Runx2 expression in hypertrophic chondrocytes impairs endochondral ossification during early skeletal development
Ganguly et al. Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction
Vinciguerra et al. mIGF‐1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart
Cowley et al. The mSin3A chromatin-modifying complex is essential for embryogenesis and T-cell development
Migliorini et al. Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice
Restivo et al. IRF6 is a mediator of Notch pro‐differentiation and tumour suppressive function in keratinocytes
Kasher et al. Direct evidence for axonal transport defects in a novel mouse model of mutant spastin‐induced hereditary spastic paraplegia (HSP) and human HSP patients
Liew et al. The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse β cells
Kim et al. FOXO1 in the ventromedial hypothalamus regulates energy balance
Nemazanyy et al. Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal disease
Xing et al. Ephrin B1 regulates bone marrow stromal cell differentiation and bone formation by influencing TAZ transactivation via complex formation with NHERF1
Gomez-Villafuertes et al. Downstream regulatory element antagonist modulator regulates Ca2+ homeostasis and viability in cerebellar neurons
Katoh-Fukui et al. Mouse Polycomb M33 is required for splenic vascular and adrenal gland formation through regulating Ad4BP/SF1 expression
Buckingham et al. Annexin 1, glucocorticoids, and the neuroendocrine–immune interface
LaFlam et al. Identification of a novel cis-regulatory element essential for immune tolerance
Amano et al. Arid5a cooperates with Sox9 to stimulate chondrocyte-specific transcription
Tremblay et al. Regulation of pTα gene expression by a dosage of E2A, HEB, and SCL
Kim et al. TRIM72 is required for effective repair of alveolar epithelial cell wounding
Saifudeen et al. A role for p53 in terminal epithelial cell differentiation